What question did this study set out to answer?

May 5, 2026

RETRACTION: Randomized Trial of Combined Cabergoline And Coasting in Preventing Ovarian Hyperstimulation Syndrome During in Vitro Fertilization/intracytoplasmic Sperm Injection Cycles.

Key Points

The aim was to evaluate the effectiveness of combined cabergoline and coasting in preventing ovarian hyperstimulation syndrome during IVF/ICSI cycles.
Claimed a randomized trial design to assess the intervention.
Reported issues with randomization allocation and methodology standards.
Provided data and explanations upon request from the editorial team.
Concerns with methodology were raised by a third party regarding randomization.
Editorial team found that reported methods did not reflect standards of a randomized clinical trial.
Data and conclusions deemed unreliable, leading to article retraction.

Abstract

RETRACTION: Y.A. Bassiouny, D.M.R. Dakhly, Y.A. Bayoumi, N.A. Salaheldin, H.A. Gouda, and A.A. Hassan, "Randomized Trial of Combined Cabergoline And Coasting in Preventing Ovarian Hyperstimulation Syndrome During In Vitro Fertilization/intracytoplasmic Sperm Injection Cycles," International Journal of Gynecology and John Wiley & Sons Ltd. A third party expressed concerns about the randomization allocation process, noting that the reported methodology does not appear to reflect the standards of a randomized clinical trial. When asked for clarification, the authors provided their study data and explanation. However, the editorial team and publisher did not feel that the answers and data alleviated the concerns with the methodology. While the work may have been undertaken in good faith, it does not meet the minimum standards to constitute a randomized study. As a result, the data and conclusions are considered unreliable, and therefore the article must be retracted.

Mark Helpful

Bookmark

Relay